Quanticate

Quanticate Welcome to Quanticate's page. We are a leading global Clinical Research Organization (CRO).

Quanticate, with headquarters in the UK and USA, is a specialist Clinical Research Organization (CRO) primarily focused on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. We provide very efficient outsourcing solutions for companies who need additional capacity or who want to outsource certain functions in their entirety. We deliver scalable on-site and off-site data management, statistical consultancy, statistical programming & analysis, medical writing and pharmacovigilance services. We also have a staff recruitment arm, "Quanticate People", to help Sponsors find all types of permanent and contract staff. Quanticate works closely with biotech, pharmaceutical and medical device companies and prides itself in being a seamless extension of its customers’ internal teams. Many of our customers choose Quanticate simply because they want to know that their data will be looked after by a specialist biometrics CRO. We offer that specific expertise and the attention necessary to properly manage, analyze and report valuable data. With a combination of on-shore and off-shore resources spanning four continents, Quanticate is renowned for its customer service, scalability and superior results.

10/02/2026

πŸ“’ NEW PODCAST EPISODE: Risk-Based Quality Management in CDM

In the latest episode of QCast, Jullia and Tom unpack risk-based quality management and why it's central to protecting participant safety and reliable trial results.

πŸ‘‚ Listen here, or on your favourite podcast provider: https://hubs.li/Q042vf_z0

🧬 Understanding Expansion Cohorts in Phase I Oncology TrialsPhase I isn’t just about dose-finding anymore. In oncology, ...
06/02/2026

🧬 Understanding Expansion Cohorts in Phase I Oncology Trials

Phase I isn’t just about dose-finding anymore. In oncology, expansion cohorts allow researchers to explore early signs of efficacy and safety in specific patient subgroups, helping to bridge the gap between initial safety and future trial phases.

This blog unpacks how expansion phases are used, their strategic benefits, and what sponsors should consider when planning early-phase oncology trials.

πŸ€” Give it a read here. https://hubs.li/Q041XQVj0

πŸŽ™οΈ QCast Episode 30: Adaptive Randomisation in Clinical TrialsIn this episode, Jullia and Tom explore adaptive randomisa...
05/02/2026

πŸŽ™οΈ QCast Episode 30: Adaptive Randomisation in Clinical Trials

In this episode, Jullia and Tom explore adaptive randomisation in clinical trials as an attractive alternative to fixed allocation when evidence is accumulating.

🎧 Available to listen now: https://hubs.li/Q041-Fgj0

πŸ§ͺ What makes observational studies essential to clinical research?While they don't involve interventions, observational ...
02/02/2026

πŸ§ͺ What makes observational studies essential to clinical research?

While they don't involve interventions, observational studies offer powerful insights. This is especially the case when assessing safety, treatment patterns, or outcomes in real-world settings.

πŸ“– Read more to understand how observational data can complement clinical trial evidence.
https://hubs.ly/Q041f53M0

🧩 Why Standardisation Matters in Clinical TrialsFrom data structure to submission formatting, standardisation improves q...
28/01/2026

🧩 Why Standardisation Matters in Clinical Trials

From data structure to submission formatting, standardisation improves quality, speeds up timelines, and reduces risk across clinical development. While it's a regulatory expectation, it can also be a strategic advantage in running trials.

Our blog explains how aligning with frameworks like CDISC early on supports data integrity, enhances interoperability, and sets trials up for long-term success.

πŸ‘· Build better trials by reading our blog. https://hubs.li/Q03_r9Lk0

27/01/2026

πŸ”¬ Observational or experimental: which study design fits your objective?

Choosing the right approach is critical for generating meaningful data in clinical research. Our blog breaks down the key differences between observational and experimental studies, and when to use each. Read about:

πŸ”Ή Study design fundamentals
πŸ”Ή Real-world examples
πŸ”Ή Implications for data interpretation

πŸ“– Explore the full blog: https://hubs.li/Q040sfVX0

πŸ’‰ Structuring PK Data for Analysis: ADaM and PharmacokineticsPharmacokinetic (PK) studies require precise data structuri...
26/01/2026

πŸ’‰ Structuring PK Data for Analysis: ADaM and Pharmacokinetics

Pharmacokinetic (PK) studies require precise data structuring to support valid analysis and regulatory compliance. Using the ADaM (Analysis Data Model) framework helps streamline this process and ensures alignment with CDISC standards.

Want to learn how ADaM datasets support robust PK analysis? We cover everything from time-point tracking to parameter derivation in our blog.

⏰ Available to read now. https://hubs.li/Q03_rcpJ0

πŸ” From Correlation to Causation: Causal Inference in Clinical TrialsUnderstanding whether a treatment causes an effect, ...
21/01/2026

πŸ” From Correlation to Causation: Causal Inference in Clinical Trials

Understanding whether a treatment causes an effect, not just correlates with one, is central to reliable evidence in clinical research.

Our blog introduces how causal inference methods help teams draw more accurate, scientifically-sound conclusions, even when working with complex or imperfect data.

πŸ“– Read our report here. https://hubs.li/Q03_r37w0

20/01/2026

🎧 QCast Episode 26: Medical Coding in Clinical Data Management

In this episode, Jullia and Tom explore what medical coding in clinical data management is and why it plays a central role in submissions and analysis-ready datasets.

πŸ‘† Listen here, and find our back catalog of podcast episodes: https://hubs.li/Q03_rgr20

πŸ’‰ Case Study: Accelerating Vaccine Development with Expert Programming When the world faced unprecedented challenges, sw...
19/01/2026

πŸ’‰ Case Study: Accelerating Vaccine Development with Expert Programming

When the world faced unprecedented challenges, swift action and specialist expertise was essential. Discover how Quanticate's world-class programming team partnered with a top-tier pharmaceutical company in the rapid development of a COVID-19 vaccine.

In this case study, you'll learn how we:

πŸ”Ή Provided tailored and scalable programming solutions to meet critical deadlines.
πŸ”Ή Managed high-stakes environments with professionalism and precision.
πŸ”Ή Ensured exceptional quality and regulatory compliance at every stage.

πŸ“– Read our full case study to see how our programming solutions, honed over 30 years of industry experience, can drive your critical projects forward: https://hubs.li/Q03_jWdC0

πŸŽ™οΈ QCast Episode 27: Machine Learning in the Pharmaceutical IndustryListen as Jullia and Tom examine how machine learnin...
16/01/2026

πŸŽ™οΈ QCast Episode 27: Machine Learning in the Pharmaceutical Industry

Listen as Jullia and Tom examine how machine learning is being applied across the pharmaceutical industry, focusing on where these methods deliver real value.

πŸ€” Find the episode here: https://hubs.li/Q03_75cs0

13/01/2026

πŸ“’ NEW PODCAST EPISODE: Real World Data Analysis in Clinical Trials

In this episode, Jullia and Tom unpack how real world data is analysed to complement clinical trials, exploring their main sources and how they support trial decisions.

πŸ‘† Click here to listen to the full episode: https://hubs.li/Q03-psGM0

Address

Bevan House, Bancroft Court
Hitchin
SG51

Alerts

Be the first to know and let us send you an email when Quanticate posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Quanticate:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram